Impact of COVID‐19 outbreak on the care of patients with inflammatory bowel disease: A comparison before and after the outbreak in South China
Autor: | Liang-Ru Zhu, Yun Qiu, Jin-Shen He, Baili Chen, Ying-Fan Zhang, Zhirong Zeng, Zhanju Liu, Marietta Iacucci, Yan Chen, Shomron Ben-Horin, Xiaozhi Li, Minhu Chen, Jin-Yu Tan, Yao He, Bo Shen, Subrata Ghosh, Ren Mao |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
China
Telemedicine medicine.medical_specialty Referral Coronavirus disease 2019 (COVID-19) Attitude of Health Personnel Inflammatory bowel disease Health Services Accessibility Disease Outbreaks 03 medical and health sciences 0302 clinical medicine COVID‐19 inflammatory bowel disease Health care Humans Medicine Practice Patterns Physicians' Retrospective Studies Health Care Rationing Hepatology business.industry Gastroenterology COVID-19 Outbreak Inflammatory Bowel Diseases medicine.disease health care Infliximab 030220 oncology & carcinogenesis Emergency medicine 030211 gastroenterology & hepatology Observational study business Attitude to Health medicine.drug |
Zdroj: | Journal of Gastroenterology and Hepatology |
ISSN: | 1440-1746 0815-9319 |
DOI: | 10.1111/jgh.15205 |
Popis: | Background and Aims Epidemics pose a great challenge to health care of patients. However, the impact of unprecedented situation of COVID‐19 outbreak on health care of inflammatory bowel disease (IBD) patients in real‐world setting has seldom been investigated. Methods We performed an observational study in a tertiary referral IBD center in China. The mode of health care and medication use was compared before and after COVID‐19 outbreak. Electronic questionnaire surveys were performed among gastroenterologists and IBD patients to investigate the impact of COVID‐19 outbreak on their attitudes towards telemedicine. Results COVID‐19 outbreak resulted in substantial decrease of patients participating in standard face‐to‐face visit during 1 month post‐outbreak (n = 51) than pre‐outbreak (n = 249), whereas the participation in telemedicine was significantly higher than comparable period in 2019 (414 vs 93). During the 1 month after COVID‐19 outbreak, 39 (39/56, 69.6%) patients had their infliximab infusion postponed with the mean delay of 3 weeks. The immunomodulator use was similar between pre‐outbreak and post‐outbreak. Six elective surgeries were postponed for a median of 43 days. In post‐outbreak period, 193 (193/297, 64.98%) of the surveyed physicians have used telemedicine with an increase of 18.9% compared with 46.13% (137/292) in the pre‐outbreak period (P |
Databáze: | OpenAIRE |
Externí odkaz: |